Lusaris Therapeutics develops small-molecule neuroplastogen therapeutics for neuropsychiatric and neurological disorders.

Lusaris Therapeutics

Andrew Levin

Lusaris is a biotechnology company advancing next-generation serotonergic neuroplastogen therapeutics to treat severe neuropsychiatric and neurological disorders. Their lead program, LSR-1019, is a proprietary sublingual formulation of 5-MeO-DMT, a rapidly acting and rapidly clearing serotonergic ps... Read more

Biotechnology Companies

Medical Organizations

Pharmaceutical Companies

Health Care Companies

Neil Buckley

Ed Monaghan

Ra Capital Management

Venrock Healthcare Capital Partners

Supportful investor in the healthcare sector

Deep Track Capital

Investment firm focusing on the life sciences

Boxer Capital

Financial services company based in Windermere, Florida

Boston

Capital and largest city of Massachusetts, United States

United States of America

Country primarily located in North America

Greater Boston

Metropolitan area in Massachusetts, New Hampshire and Rhode Island, USA

Massachusetts

Suffolk County

Research and Development in Biotechnology (except Nanobiotechnology)

Research and Development in the Physical, Engineering, and Life Sciences

Scientific Research and Development Services

Professional, Scientific, and Technical Services

Nursing and Residential Care Facilities

Pharmaceutical Preparation Manufacturing

Pharmaceutical and Medicine Manufacturing

Chemical Manufacturing

Manufacturing

Health Care and Social Assistance

Health Care and Social Assistance, Health

Catalent

Commercial Physical And Biological Research

Research, Development, And Testing Services

Engineering, Accounting, Research, Management, And Related Services

Pharmaceutical Preparations

Drugs

Chemicals And Allied Products

Offices And Clinics Of Health Practitioners, Not Elsewhere Classified

Offices And Clinics Of Other Health Practitioners

Health Services

Biotechnology company advancing next-generation therapeutics

MediaElement.js

Typekit

Google Font API

Swiper Slider

jQuery Migrate

Google Remarketing Tag

Sectigo

nginx

Google Analytics

jQuery

MySQL

Divi

Google Tag Manager

Animate.css

WordPress

Lusaris Therapeutics Funding & Investors

Total Amount Raised: $60,000,000

Lusaris Therapeutics Funding Rounds

Series A Investors

💸 Investors

📚 Popular Blog Posts